DMC Biotechnologies welcomes Doug Cameron to the team as an Independent Board member. He joins the Board effective immediately to support DMC’s growth as it moves to commercialisation.
Doug brings more than 30 years of experience in the biotech industry and has deep knowledge of technology, commercialisation, venture capital and private equity. He earned a Ph.D. in Biochemical Engineering from MIT and has worked for Cargill, Khosla Ventures and First Green Partners, among others.
Doug Cameron said: “I have been following DMC for some time as they have demonstrated their technology and advanced from development to commercial deployment. I look forward to joining the team and supporting management as they bring their first products to market.”
Matt Lipscomb, Ph.D., CEO & Co-Founder of DMC said:“Doug is a luminary in the field of biotechnology and has been influential in the success of multiple companies in the sector. We are excited and honored to have him join the DMC Board. Doug’s appointment to the Board is another important milestone in our growth as an organisation.”